MIPS Technologies, Inc. (Nasdaq:MIPS), a leading provider of industry-standard processor architectures and cores for digital consumer, home networking, wireless, communications and business applications, reported that the latest Ethernet switch families from Vitesse Semiconductor Corporation, a leading provider of advanced IC solutions for Carrier and Enterprise networks, are powered by MIPS(r) processors.
Both the newest members of the SparX-III(tm) Ethernet switch family and the new Caracal(tm) family of Ethernet switches take advantage of MIPS' performance/power efficiency advantages and feature Vitesse's EcoEthernet(tm) v2.0 green technology, delivering high levels of energy efficiency along with high performance to address increasing network bandwidth.
Proteonomix, Inc., (OTCBB: PROT) is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives.
Proteoderm, Inc. a wholly owned subsidiary of PROT that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.'s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (NYSE:CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is PROT's operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. ("PRTMI") intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine.
PROT intends to create and dedicate a subsidiary to each of its technologies.
** PROT has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.
This is another step in the development of PROT’s intellectual property and getting StromaCel into the commercial market.
The technology covered by the patent application will reduce the cost to the patient of this type of treatment and when trials are completed and regulatory approvals are obtained PROT believes that the stromal cell technology will have major importance in the treatment of cardiac damage caused by heart attacks.
More about PROT at www.proteonomix.com
Steiner Leisure Limited (Nasdaq:STNR) reported entry into an agreement to operate a Mandara luxury spa facility at the expanded Harrah's Cherokee Casino & Hotel in North Carolina.
The term of this agreement is five years from the opening date of the spa.
At the Solar Power International Conference in Los Angeles, American Electric Technologies, Inc. (Nasdaq:AETI), the premium provider of power delivery solutions for the traditional and renewable energy industries, and Wiscom Systems Company, Ltd. (Shenzen Stock Exchange:WISCOM, code 002090) of Nanjing, China, reported the signing of a memorandum of understanding to form a joint venture in China to develop and market power converters and inverters for the Chinese wind and solar markets.
EasyLink Services International Corporation (Nasdaq:ESIC), a global provider of comprehensive messaging services and e-commerce solutions, reported that a popular global social networking site has selected ESIC's fax services to facilitate law enforcement communication and safety on the social network.
Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty thousand dollars in cash and twenty thousand dollars in free trading shares from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (OTCPK:PROT).